Biologically synthesized silver nanoparticles as potent antibacterial effective against multi drug-resistant Pseudomonas aeruginosa

Pseudomonas aeruginosa is one of the most worrisome infectious bacteria due to its intrinsic and acquired resistance against several antibiotics and the recalcitrance of its infections; hence, the development of novel antimicrobials able to inhibit it is mandatory. In this work, silver nanoparticles...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Letters in applied microbiology 2022-06
Hauptverfasser: Campo-Beleño, Cristhian, Villamizar-Gallardo, Raquel Amanda, López-Jácome, Luis Esaú, González, Edgar E, Muñoz-Carranza, Sergio, Franco, Bernardo, Morales-Espinosa, Rosario, Coria-Jimenez, Rafael, Franco-Cendejas, Rafael, Hernández-Durán, Melissa, Lara-Martínez, Reyna, Jiménez-García, Luis Felipe, Fernández-Presas, Ana María, García-Contreras, Rodolfo
Format: Artikel
Sprache:eng
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:Pseudomonas aeruginosa is one of the most worrisome infectious bacteria due to its intrinsic and acquired resistance against several antibiotics and the recalcitrance of its infections; hence, the development of novel antimicrobials able to inhibit it is mandatory. In this work, silver nanoparticles obtained by green synthesis using a leaf extract and fungi were tested against a battery of clinical strains from cystic fibrosis, pneumonia, and burnt patients, some of them with multidrug resistance. Both nanoparticles showed a potent antibacterial effect, causing severe damage to the cell wall, membrane, and DNA, and inducing the production of reactive oxygen species. Moreover, the nanoparticles derived from fungi showed synergistic antibacterial effects with the antibiotics meropenem and levofloxacin for some clinical strains and both kinds of nanoparticles were nontoxic for larvae of the moth Galleria mellonella, encouraging further research for their implementation in the treatment of P. aeruginosa infections.
ISSN:1472-765X